Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis
Compositions comprising truncated tryptophanyl-tRNA synthetase polypeptides useful for regulating angiogenesis, as well as nucleic acids encoding such tRNA synthetase polypeptides are described. Methods of making and using such compositions are also disclosed.
1. An isolated nucleic acid comprising a polynucleotide encoding an amino-terminal truncated human tryptophanyl-tRNA synthetase (TrpRS) polypeptide capable of regulating angiogenesis comprising a carboxyl-terminal portion of TrpRS, which has the amino acid sequence of residues 1 to 471 of SEQ ID NO: 10, the polypeptide including a Rossmann fold nucleotide binding domain; wherein the polypeptide does not comprise amino acid residues 1-47 of SEQ ID NO: 10.
2. The isolated nucleic acid of claim 1 , wherein the polypeptide comprises amino acid residues 71-471 of SEQ ID NO: 10.
3. The isolated nucleic acid of claim 1 , wherein the polypeptide comprises amino acid residues 48-471 of SEQ ID NO: 10.
4. The isolated nucleic acid of claim 1 , comprising a leader polynucleotide fused to the polynucleotide encoding the amino-terminal truncated human tryptophanyl-tRNA synthetase polypeptide and in an open reading frame therewith, the leader polynucleotide encoding a secretory peptide sequence for controlling transport of the polypeptide from a cell.
5. A recombinant vector comprising the polynucleotide of claim 1 .
6. A recombinant vector comprising the polynucleotide of claim 4 .
7. A method of making a recombinant host cell comprising introducing the polynucleotide of claim 1 into the host cell.
8. An isolated recombinant host cell which includes the polynucleotide of claim 1 and expresses the polypeptide.
9. An isolated recombinant host cell which includes the polynucleotide of claim 4 and expresses the polypeptide.
10. A method of making an isolated polypeptide comprising:
(a) culturing the recombinant host cell of claim 8 ; and
(b) isolating from the cell culture the amino-terminal truncated human tryptophanyl-tRNA synthetase polypeptide.
11. A method of making an isolated polypeptide comprising:
(a) culturing the recombinant host cell of claim 9 ; and
(b) isolating from the cell culture the amino-terminal truncated human tryptophanyl-tRNA synthetase polypeptide.
12. An isolated nucleic acid comprising a polynucleotide encoding an amino-terminal truncated human tryptophanyl-tRNA synthetase (TrpRS) polypeptide having chemokine activity comprising a carboxyl-terminal portion of TrpRS, which has the amino acid sequence of residues 1 to 471 of SEQ ID NO: 10, the polypeptide including a Rossmann fold nucleotide binding domain; wherein the polypeptide does not comprise amino acid residues 1-47 of SEQ ID NO: 10.
13. The isolated nucleic acid of claim 12 , wherein the polypeptide comprises amino acid residues 71-471 of SEQ ID NO: 10.
14. The isolated nucleic acid of claim 12 , wherein the polypeptide comprises amino acid residues 48-471 of SEQ ID NO: 10.
15. The isolated nucleic acid of claim 12 , comprising a leader polynucleotide fused to the polynucleotide encoding the amino-terminal truncated human tryptophanyl-tRNA synthetase polypeptide and in an open reading frame therewith, the leader polynucleotide encoding a secretory peptide sequence for controlling transport of the polypeptide from a cell.
16. A recombinant vector comprising the polynucleotide of claim 12 .
17. A method of making a recombinant host cell comprising introducing the polynucleotide of claim 12 into the host cell.
18. An isolated recombinant host cell which includes the polynucleotide of claim 12 and expresses the polypeptide.
19. A method of making an isolated polypeptide comprising:
(a) culturing the recombinant host cell of claim 18 ; and
(b) isolating from the cell culture the amino-terminal truncated human tryptophanyl-tRNA synthetase polypeptide.
20. A method of suppressing angiogenesis in a mammal comprising administering to the mammal an angiostatically effective amount of a composition comprising the isolated nucleic acid of claim 1 .
21. The method of claim 20 wherein the polypeptide encoded by the isolated nucleic acid comprises amino acid residues 48-471 of SEQ ID NO: 10 or amino acid residues 71-471 of SEQ ID NO: 10.
22. The method of claim 20 wherein the nucleic acid comprises a leader polynucleotide fused to the polynucleotide encoding the amino-terminal truncated human tryptophanyl-tRNA synthetase polypeptide and in an open reading frame therewith, the leader polynucleotide encoding a secretory peptide sequence for controlling transport of the polypeptide from a cell.